Literature DB >> 15168152

Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up.

Yu-Shu Chen1, Yao-Hsu Yang, Yu-Tsai Lin, Bor-Luen Chiang.   

Abstract

The objective of this study was to investigate infection and sepsis in hospitalised children with systemic lupus erythematosus (SLE). Between 1991 and 2000 we reviewed 72 episodes of suspected infection in 42 children with SLE from all hospitalised children with SLE at a medical center in Taiwan. Data comprised clinical and laboratory characteristics of SLE at the time of infection. Infections were identified and categorised as minor or major. A total of 125 patients (110 girls, 15 boys) were admitted 557 times. Forty-two patients had infections, giving an infection rate of 33.6%. There were a total of 72 infections including 20 proven infections; 61 cases of these were minor infections and 11 cases of these were major infections (10 cases were sepsis). Four patients died because of sepsis. By univariate analysis, major infection (sepsis) was significantly associated with a high SLE disease activity index score, lower complement levels and higher anti-DNA titres. In conclusion, our data confirm that infection is common in hospitalised children with SLE. Sepsis, most frequent in major infections, is associated with disease activity and causes significant mortality. These facts should be borne in mind when children with SLE are hospitalised.

Entities:  

Mesh:

Year:  2004        PMID: 15168152     DOI: 10.1007/s10067-004-0877-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.

Authors:  W U Kim; J K Min; S H Lee; S H Park; C S Cho; H Y Kim
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

2.  Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors.

Authors:  S Studenski; N B Allen; D S Caldwell; J R Rice; R P Polisson
Journal:  Arthritis Rheum       Date:  1987-12

3.  Criteria for assessing disease activity in systemic lupus erythematosus.

Authors:  D Isenberg; P Bacon; C Bombardier; D Gladman; C H Goldsmith; K Kalunian; M Liang; P Maddison; O Nived; M Richter
Journal:  J Rheumatol       Date:  1989-10       Impact factor: 4.666

4.  Infections associated with juvenile systemic lupus erythematosus.

Authors:  S M Al-Mayouf; S Al-Jumaah; S Bahabri; W Al-Eid
Journal:  Clin Exp Rheumatol       Date:  2001 Nov-Dec       Impact factor: 4.473

5.  Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms.

Authors:  D B Hellmann; M Petri; Q Whiting-O'Keefe
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

6.  Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.

Authors:  B D Pryor; S G Bologna; L E Kahl
Journal:  Arthritis Rheum       Date:  1996-09

7.  Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus.

Authors:  E Ginzler; H Diamond; D Kaplan; M Weiner; M Schlesinger; M Seleznick
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

8.  Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort.

Authors:  M M Ward; E Pyun; S Studenski
Journal:  Arthritis Rheum       Date:  1995-10

9.  Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death.

Authors:  J D Reveille; A Bartolucci; G S Alarcón
Journal:  Arthritis Rheum       Date:  1990-01

10.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

Authors:  D J Wallace; T Podell; J Weiner; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272

View more
  3 in total

1.  Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide.

Authors:  Kamolwish Laoprasopwattana; Pornsak Dissaneewate; Prayong Vachvanichsanong
Journal:  Pediatr Nephrol       Date:  2009-03-12       Impact factor: 3.714

Review 2.  Diagnosis and management of infectious complications of childhood rheumatic diseases.

Authors:  Rhina D Castillo; Wendy De la Pena; Katherine A B Marzan
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

3.  High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-alpha by increased numbers of dendritic cells.

Authors:  N Koike-Kiriyama; Y Adachi; M Iwasaki; Y Amou; A Shigematsu; Y Koike; K Minamino; H Mukaide; M Shi; S Yanai; M Matsumura; S Ikehara
Journal:  Clin Exp Immunol       Date:  2008-09-08       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.